WORK Medical Technology (WOK) Debt Ratio (2023 - 2025)
WORK Medical Technology (WOK) posted Debt Ratio of 0.19 for Q3 2025, down 48.07% on a QoQ basis from 0.37 in Q1 2025, and down 47.55% year-over-year from 0.37 in Q3 2024.
WORK Medical Technology (WOK) has 3 years of Debt Ratio data on file, last reported at 0.19 in Q3 2025.
- In Q3 2025, Debt Ratio fell 47.55% year-over-year to 0.19; the TTM figure through Sep 2025 stood at 0.19 (down 47.55% YoY), while the FY2025 annual figure was 0.19, down 47.55% from the prior year.
- Debt Ratio slipped to 0.19 in Q3 2025, from 0.37 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.37 in Q1 2025 and bottomed at 0.19 in Q3 2025.
- A 3-year average of 0.31 and a median of 0.33 in 2023 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2024 — Debt Ratio rose 24.55% — and 2025, when it slumped 47.55%.
- Year by year, Debt Ratio stood at 0.3 in 2023, then grew by 24.55% to 0.37 in 2024, then sank by 47.55% to 0.19 in 2025.
- The last three Debt Ratio figures came in at 0.19 (Q3 2025), 0.37 (Q1 2025), and 0.37 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | WORK Medical Technology | - | - | - | 0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.37 |
| Sep 30, 2024 | 0.37 |
| Sep 30, 2023 | 0.30 |